Oragenics Net Debt from 2010 to 2026
| OGEN Stock | USD 0.65 0.01 1.52% |
Net Debt | First Reported 2003-06-30 | Previous Quarter 1 M | Current Value -11 M | Quarterly Volatility 9 M |
Check Oragenics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oragenics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 33.3 K, Interest Expense of 25.5 K or Selling General Administrative of 4.3 M, as well as many indicators such as Price To Sales Ratio of 2.9 K, Dividend Yield of 4.0E-4 or Days Sales Outstanding of 7.16. Oragenics financial statements analysis is a perfect complement when working with Oragenics Valuation or Volatility modules.
Oragenics | Net Debt | Build AI portfolio with Oragenics Stock |
Evaluating Oragenics's Net Debt across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Oragenics's fundamental strength.
Latest Oragenics' Net Debt Growth Pattern
Below is the plot of the Net Debt of Oragenics over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Oragenics' Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Oragenics' overall financial position and show how it may be relating to other accounts over time.
| Net Debt | 10 Years Trend |
|
Net Debt |
| Timeline |
Oragenics Net Debt Regression Statistics
| Arithmetic Mean | (8,462,793) | |
| Geometric Mean | 5,488,229 | |
| Coefficient Of Variation | (102.63) | |
| Mean Deviation | 7,077,180 | |
| Median | (6,085,665) | |
| Standard Deviation | 8,685,300 | |
| Sample Variance | 75.4T | |
| Range | 33.8M | |
| R-Value | (0.02) | |
| Mean Square Error | 80.4T | |
| R-Squared | 0.0003 | |
| Significance | 0.95 | |
| Slope | (28,919) | |
| Total Sum of Squares | 1207T |
Oragenics Net Debt History
Other Fundumenentals of Oragenics
Oragenics Net Debt component correlations
Click cells to compare fundamentals
About Oragenics Financial Statements
Oragenics investors utilize fundamental indicators, such as Net Debt, to predict how Oragenics Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Debt | -482.7 K | -506.8 K | |
| Net Debt To EBITDA | 0.05 | 0.04 |
Pair Trading with Oragenics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Oragenics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oragenics will appreciate offsetting losses from the drop in the long position's value.Moving together with Oragenics Stock
| 0.79 | EDIT | Editas Medicine Earnings Call This Week | PairCorr |
Moving against Oragenics Stock
| 0.77 | DSGN | Design Therapeutics | PairCorr |
| 0.55 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.47 | ENGN | enGene Holdings Common | PairCorr |
| 0.36 | KYTX | Kyverna Therapeutics | PairCorr |
| 0.31 | 63E | ONWARD MEDICAL BV | PairCorr |
The ability to find closely correlated positions to Oragenics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Oragenics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Oragenics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Oragenics to buy it.
The correlation of Oragenics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Oragenics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Oragenics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Oragenics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Oragenics Correlation against competitors. To learn how to invest in Oragenics Stock, please use our How to Invest in Oragenics guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Will Biotechnology sector continue expanding? Could Oragenics diversify its offerings? Factors like these will boost the valuation of Oragenics. Anticipated expansion of Oragenics directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Oragenics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Oragenics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Oragenics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Oragenics' market price to deviate significantly from intrinsic value.
It's important to distinguish between Oragenics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Oragenics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Oragenics' market price signifies the transaction level at which participants voluntarily complete trades.